137 related articles for article (PubMed ID: 8388582)
1. Postoperative deep venous thrombosis (DVT) and low-molecular weight heparin (LMWH) type and dosage.
Wicky J; Couson F; Ambrosetti P; Didier D; Rohner A; Bounameaux H
Thromb Haemost; 1993 Apr; 69(4):402-3. PubMed ID: 8388582
[No Abstract] [Full Text] [Related]
2. [Role of low molecular weight heparin in the prevention of postoperative deep venous thrombosis. Our experience in 88 cases].
Verardi S; Cortese F; Baroni B; Boffo V; Casciani CU
G Chir; 1989 Nov; 10(11):674-8. PubMed ID: 2562010
[TBL] [Abstract][Full Text] [Related]
3. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
Marbet GA
Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
[TBL] [Abstract][Full Text] [Related]
4. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials.
Howard AW; Aaron SD
Thromb Haemost; 1998 May; 79(5):902-6. PubMed ID: 9609217
[TBL] [Abstract][Full Text] [Related]
6. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
[TBL] [Abstract][Full Text] [Related]
7. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
Hauch O; Khattar SC; Jørgensen LN
Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
[TBL] [Abstract][Full Text] [Related]
8. Role of granulocytes in the development of venous thrombosis in patients with hip fractures.
Monreal M; Lafoz E; Arias A; Casals A
Haemostasis; 1991; 21(1):45-50. PubMed ID: 1650746
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
Bergqvist D
Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
[No Abstract] [Full Text] [Related]
10. [Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty].
Yang Z; Liu X; Dai S; Liu K; Zhang Y; Sun J; Yin X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep; 24(9):1058-61. PubMed ID: 20939473
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG
Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of thrombosis in minimally invasive surgery].
Harenberg J
Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
[No Abstract] [Full Text] [Related]
13. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
[TBL] [Abstract][Full Text] [Related]
14. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
Hamann H
Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
[TBL] [Abstract][Full Text] [Related]
15. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
Tapson VF; Hull RD
Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin (fraxiparine) to prevent deep vein thrombosis in patients undergoing orthopedic surgery: a clinical report of two regimens.
Drouet JC; Bernard JM; Bourreli B; Gunst JP
Haemostasis; 1988; 18(2):135-6. PubMed ID: 2842239
[No Abstract] [Full Text] [Related]
17. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
Turpie AG
Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
[No Abstract] [Full Text] [Related]
18. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
Daiss W; Dölle W
Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
[No Abstract] [Full Text] [Related]
19. Enoxaparin prophylaxis in elective hip surgery.
Turpie AG
Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
[TBL] [Abstract][Full Text] [Related]
20. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
